Deletion of the carboxyl-terminal exons of K-sam/FGFR2 by short homology-mediated recombination, generating preferential expression of specific messenger RNAs

Cancer Research

Volumn 59, Issue 24, 1999, Pages 6080-6086

  Ueda, Tetsuya ^a,b   Sasaki, Hiroki ^a   Kuwahara, Yoshitaka ^a   Nezu, Masahiko ^a   Shibuya, Tetsuo ^c   Sakamoto, Hiromi ^a   Ishii, Hideshi ^a   Yanagihara, Kazuyoshi ^a   Mafune, Ken Ichi ^b   Makuuchi, Masatoshi ^b   Terada, Masaaki ^a,d  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c IBM JAPAN LTD   (Japan)

^d NATIONAL CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR; MESSENGER RNA; PROTEIN TYROSINE KINASE;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL STRAIN 3T3; CELL TRANSFORMATION; CHROMOSOME 10Q; DNA SEQUENCE; EXON; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION; GENETIC RECOMBINATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; STOMACH CANCER;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELL LINE; EXONS; GENE DELETION; HUMANS; MICE; MOLECULAR SEQUENCE DATA; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RECEPTORS, FIBROBLAST GROWTH FACTOR; RECOMBINATION, GENETIC; RNA, MESSENGER; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY, NUCLEIC ACID; TUMOR CELLS, CULTURED;

EID: 0033572418     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Brison, O. Gene amplification and tumor progression. Biochem. Biophys. Acta, 1155: 25-41, 1993.
2. Sakamoto, H., Mori, M., Taira, M., Yoshida, T., Matsukawa, S., Shimizu, K., Sekiguchi, M., Terada, M., and Sugimura, T. Transforming gene from human stomach cancers and a noncancerous portion of stomach mucosa. Proc. Natl. Acad. Sci. USA, 83: 3997-4001, 1986.
3. Yoshida, M., Wada, M., Satoh, H., Yoshida, T., Sakamoto, H., Miyagawa, K., Yokota, J., Koda, T., Kakinuma, M., Sugimura, T., and Terada, M. Human HST1(HSTF1) gene maps to chromosome band 11q13 and coamplifies with the INT2 gene in human cancer. Proc. Natl. Acad. Sci. USA, 85: 4861-4864, 1988.
4. Tsuda, T., Tahara, E., Kajiyama, G., Sakamoto, H., Terada, M., and Sugimura, T. High incidence of coamplification of hst-1 and int-2 genes in human esophageal carcinomas. Cancer Res., 49: 5505-5508, 1989.
5. Hamaguchi, M., Sakamoto, H., Tsuruta, H., Sasaki, H., Muto, T., Sugimura, T., and Terada, M. Establishment of a highly sensitive and specific exon-trapping system. Proc. Natl. Acad. Sci. USA, 89: 9779-9783, 1992.
6. Akiyama, N., Tsuruta, H., Sasaki, H., Sakamoto, H., Hamaguchi, M., Ohmura, Y., Seto, M., Ueda, R., Hirai, H., Yazaki, Y., Sugimura, T., and Terada, M. Messenger RNA levels of five genes located at chromosome 11q13 in B-cell tumors with chromosome translocation t(11;14) (q13;q.32). Cancer Res., 54: 377-379, 1994.
7. Kishi, T., Sasaki, H., Akiyama, N., Ishizuka, T., Sakamoto, H., Aizawa, S., Sugimura, T., and Terada, M. Molecular cloning of human GRB-7 co-amplified with CAB1 and c-ERBB-2 in primary gastric cancer. Biochem. Biophys. Res. Commun., 232: 5-9, 1997.
8. Akiyama, N., Sasaki, H., Ishizuka, T., Kishi, T., Sakamoto, H., Onda, M., Hirai, H., Yazaki, Y., Sugimura, T., and Terada, M. Isolation of a candidate gene, CAB1, for cholesterol transport to mitochondria from the c-ERRB-2 amplicon by a modified cDNA selection method. Cancer Res., 57: 3548-3553, 1997.
9. Shinozaki, H., Ozawa, S., Ando, N., Tsuruta, H., Terada, M., Ueda, M., and Kitajima, M. CyclinD1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information. Clin. Cancer Res., 2: 1155-1161, 1996.
10. Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., and McGuire, W. L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science (Washington DC), 235-177-182, 1987.
11. Suire, J. A., Thorner, P. S., Weitzman, S., Maggi, J. D., Dirk, P., Doyle, J., Hale, M., and Godbout, R. Co-amplification of MYCN and a DEAD box gene (DDX1) in primary neuroblastoma. Oncogene. 10: 1417-1422, 1995.
12. Forus, A., Florenes, V. A., Maelandsmo, G. M., Meltzer, P. S., Fodstad, O., and Myklebost, O. Mapping of amplification units in the q13-14 region of chromosome 12 in human sarcomas: some amplica do not include. MDM2. Cell Growth & Differ., 4: 1065-1070, 1993.
13. Reifenberger, G., Reifenberger, J., Ichimura, K., Meltzer, P. S., and Collins, V. P. Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2. Cancer Res., 54: 4299-4303, 1994.
14. Sen, S., Zhou, H., and White, R. A. A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines. Oncogene. 14: 2195-2200, 1997.
15. Anzick, S. L., Kononen, J., Walker, R. L., Azorsa, D. O., Tanner, M. M., Guan, X-Y., Sauter, G., Kallionniemi, O-A., Trent, J. M., and Meltzer, P. S. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science (Washington DC), 277: 965-968, 1997.
16. Nakatani, H., Sakamoto, H., Yoshida, T., Yokota, J., Tahara, E., Sugimura, T., and Terada, M. Isolation of an amplified DNA sequence in stomach cancer. Jpn. J. Cancer Res., 81: 707-710, 1990.
17. Hattori, Y., Odagiri, H., Nakatani, H., Miyagawa, K., Naito, K., Sakamoto, H., Katoh, O., Yoshida, T., Sugimura, T., and Terada, M. K-sam, an amplified gene in stomach cancer, is a member of the heparin-binding growth factor receptor genes. Proc. Natl. Acad. Sci. USA, 87: 5983-5987, 1990.
18. Hattori, Y., Itoh, H., Uchino, S., Hosokawa, K., Ochiai, A., Ino, Y., Ishii, H., Sakamoto, H., Yamaguchi, N., Yanagihara, K., Hirohashi, S., Sugimura, T., and Terada, M. Immunohistochemical detection of K-sam protein in stomach cancer. Clin. Cancer Res., 2: 1373-1381, 1996.
19. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
20. Itoh, H., Hattori, Y., Sakamoto, H., Iishii, H., Kishi, T., Sasaki, H., Yoshida, T., Koono, M., Sugimura, T., and Terada, M. Preferential alternative splicing in cancer generates a K-sam messenger RNA with higher transforming activity. Cancer Res., 54: 3237-3241, 1994.
21. Katoh, M., Hattori, Y., Sasaki, H.,Tanaka, M., Sugano, K., Yazaki, Y., Sugimura, T., and Terada, M. K-sam gene encodes secreted as well as transmembrane receptor tyrosine kinase. Proc. Natl. Acad. Sci. USA, 89: 2960-2964, 1992.
22. Dionne, C. A., Crumley, G., Bellot, F., Kaplow, J. M., Searfoss, G., Ruta, M., Burgess, W. H., Jaye, M., and Schlessinger, J. Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors. EMBO J., 9: 2685-2692, 1990.
23. Champion-Arnaud, P., Ronsin, C., Gilbert, E., Gesnel, M. C., Houssaint, E., and Breathnach, R. Multiple mRNAs code for proteins related to the BEK fibroblast growth factor receptor. Oncogene, 6: 979-987, 1991.
24. Crumley, G., Bellot, F., Kaplow, J. M., Schlessinger, J., Jaye, M., and Dionne, C. A. High-affinity binding and activation of a truncated FGF receptor by both aFGF and bFGF. Oncogene, 6: 2255-2262, 1991.
25. Johnson, D. E., Lu, J., Chen, H., Werner, S., and Williams, L. T. The human fibroblast growth factor receptor genes: a common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain. Mol. Cell. Biol., 11: 4627-4634, 1991.
26. Miki, T., Bottaro, D. P., Fleming, T. P., Smith, C. L., Burgess, W. H., Chan, A. M-L., and Aaronson, S. A. Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. Proc. Natl. Acad. Sci. USA, 89: 246-250, 1992.
27. Ishii, H., Yoshida, T., Oh, H., Yoshida, S., and Terada, M. A truncated K-sam product lacking the distal carboxyl-terminal portion provides a reduced level of autophosphorylation and greater resistance against induction of differentiation. Mol. Cell. Biol., 15: 3664-3671, 1995.
28. Mohammadi, M., Honegger, A. M., Rotin, D., Fischer, R., Bellot, F., Li, W., Dionne, C. A., Jaye, M., Rubinstein, M., and Schlessinger, J. A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-γ I. Mol. Cell. Biol., 11: 5068-5078, 1991.
29. 2+ flux but not mitogenesis. Nature (Lond.), 358: 678-681, 1992.
30. Mohammadi, M., Dionne, C. A., Li, W., Li, N., Spivak, T., Honegger, A. M., Jaye, M., and Schlessinger, J. Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis. Nature (Lond.), 358: 681-684, 1992.
31. Huang, J., Mohammadi, M., Rodrigues, G. A., and Schlessinger, J. Reduced activation of RAF-1 and MAP kinase by a fibroblast growth factor receptor mutant deficient in stimulation of phosphatidylinositol hydrolysis. J. Biol. Chem., 270: 5065-5072, 1995.
32. Lorenti, M. V., Castagnino, P., Chen, Q., Chedid, M., and Miki, T. Ligand-independent activation of fibroblast growth factor receptor-2 by carboxyl terminal alterations. Oncogene, 15: 817-826, 1997.
33. Moscatello, D. K., Holgado-Madruga, M., Emlet, D. R., Montgomery, R. B., and Wong, A. J. Constitutive activation of phosphatidylinositol 3-kinase by a naturally occurring mutant epidermal growth factor receptor. J. Biol. Chem., 273: 200-206, 1998.
34. Zhu, X., Daffada, A. A., Chan, C. M., and Dowsett, M. Identification of an exon 3 deletion splice variant androgen receptor mRNA in human breast cancer. Int. J. Cancer. 72: 574-580, 1997.
35. Ide, H., Katoh, M., Sasaki, H., Yoshida, T., Aoki, K., Nawa, Y., Osada, Y., Sugimura, T., and Terada, M. Cloning of human bone morphogenetic protein type IB receptor (BMPR-IB) and its expression in prostate cancer in comparison with other BMPRs. Oncogene, 14: 1377-1382, 1997.
36. Takahama, Y., Ochiya, T., Sasaki, H., Baba-Toriyama, H., Konishi, H., Nakano, H., and Terada, M. Molecular cloning and functional analysis of cDNA encoding a rat leukemia inhibitory factor: towards generation of pluripotent rat embryonic stem cells. Oncogene, 16: 3189-3196, 1998.
37. Windle, B., Draper, B. W., Yin, Y., O'German, S., and Wahl, G. M. A central role for chromosome breakage in gene amplification, deletion formation, and amplicon integration. Genes Dev., 5: 160-174, 1991.
38. Pipiras, E., Coquelle, A., Bieth, A., and Debatisse, M. Interstitial deletions and intrachromosomal amplification initiated from a double-strand break targeted to a mammalian chromosome. EMBO J., 17: 325-333, 1998.
39. Amler, L. C., and Schwab, M. Multiple amplicon of discrete sizes encompassing N-myc in neuroblastoma cells evolve through differential recombination from a large precursor DNA. Oncogene, 7: 807-809, 1992.
40. Schneider, S. S., Hiemstra, J. L., Zehnbauer, B. A., Taillon-Miller, P., Le Paslier, D. L., Vogelstein, B., and Brodeur, G. M. Isolation and structural analysis of a 1.2-megabase N-myc amplicon from a human neuroblastoma. Mol. Cell. Biol., 12: 5563-5570, 1992.
41. Pomykala, H. M., Bohlander, S. K., Broeker, P. L., Olopade, O. I., and Diaz, M. O. Breakpoint junctions of chromosome 9p deletions in two human glioma cell lines. Mol. Cell. Biol., 14: 7604-7610, 1994.
42. Kohno, T., Otsuka, T., Inazawa, J., Abe, T., and Yokota, J. Breakpoint junction of interstitial homozygous deletion at chromosome 2q33 in a small cell lung carcinoma. DNA Res., 3: 421-424, 1996.
43. Inoue, H., Ishii, H., Alder, H., Snyder, E., Druck, T., Huebner, K., and Croce, C. M. Sequence of the FRA3B common fragile region: implications for the mechanism of FHIT deletion. Proc. Natl. Acad. Sci. USA, 94: 14584-14589, 1997.
44. Canning, S., and Dryja, T. P. Short, direct repeats at the breakpoints of deletions of the retinoblastoma gene. Proc. Natl. Acad. Sci. USA, 86: 5044-5048, 1989.
45. Strout, M. P., Marcucci, G., Bloomfield, C. D., and Caligiuri, M. A. The partial tandem duplication of ALL1 (MLL) is consistently generated by Alu-mediated homologous recombination in acute mycloid leukemia. Proc. Natl. Acad. Sci. USA, 95: 2390-2395, 1998.